...
机译:AxicabTagene CiLoleucel(AXI-CEL)CD19嵌合抗原受体(汽车)T细胞治疗复发/难治性大B细胞淋巴瘤:现实世界经验
Univ Texas MD Anderson Canc Ctr Dept Lymphoma &
Myeloma Houston TX USA;
H Lee Moffitt Canc Ctr &
Res Inst Tampa FL USA;
Stanford Univ Med Ctr Stanford CA 94305 USA;
Washington Univ Sch Med St Louis MO USA;
Mayo Clin Div Hematol Rochester MN USA;
Univ Maryland Sch Med Baltimore MD 21201 USA;
Univ Nebraska Med Ctr Omaha NE USA;
Univ Miami Miller Sch Med Sylvester Comprehens Canc Ctr Miami FL 33136 USA;
Univ Rochester Med Ctr Div Hematol Oncol Wilmot Canc Inst Rochester NY 14642 USA;
Vanderbilt Ingram Canc Ctr Nashville TN USA;
Univ Kansas Med Ctr Div Hematol Malignancies &
Cellular Therapeut Westwood KS USA;
Wayne State Univ Dept Oncol Karmanos Canc Inst Blood &
Marrow Stem Cell Transplant Program;
UPMC Hillman Canc Ctr Pittsburgh PA USA;
Hackensack Meridian Hlth John Theurer Canc Ctr Hackensack NJ USA;
Cleveland Clin Fdn Dept Hematol &
Med Oncol Taussig Canc Inst 9500 Euclid Ave Cleveland OH;
Univ Calif San Francisco Helen Diller Family Comprehens Canc Ctr San Francisco CA 94143 USA;
Banner MD Anderson Canc Ctr Gilbert AZ USA;
Univ Texas MD Anderson Canc Ctr Div Canc Med Dept Lymphoma &
Myeloma Houston TX 77030 USA;
H Lee Moffitt Canc Ctr &
Res Inst Tampa FL USA;
Washington Univ Sch Med Dept Med Div Oncol St Louis MO 63110 USA;
Mayo Clin Div Hematol Rochester MN USA;
Univ Maryland Med Ctr Sch Med Greenebaum Comprehens Canc Ctr Baltimore MD 21201 USA;
Univ Nebraska Med Ctr Omaha NE USA;
Stanford Univ Dept Med Div Blood &
Marrow Transplantat Stanford CA 94305 USA;
Univ Texas MD Anderson Canc Ctr Dept Lymphoma &
Myeloma Houston TX USA;
H Lee Moffitt Canc Ctr &
Res Inst Tampa FL USA;
机译:AxicabTagene CiLoleucel(AXI-CEL)CD19嵌合抗原受体(汽车)T细胞治疗复发/难治性大B细胞淋巴瘤:现实世界经验
机译:AxicabTagene Ciloleucel,一种抗CD19嵌合抗原受体T细胞治疗,用于复发或难治性大B细胞淋巴瘤:对社区肿瘤学家的实际影响
机译:AxicabTagene Ciloleucel,一种抗CD19嵌合抗原受体T细胞治疗,用于复发或难治性大B细胞淋巴瘤:对社区肿瘤学家的实际影响
机译:嵌合抗原受体(汽车)T细胞治疗,我们可以利用成功吗?
机译:嵌合抗原受体T细胞疗法对B细胞恶性肿瘤的治疗潜力。
机译:Axicabtagene Ciloleucel一种抗CD19嵌合抗原受体T细胞疗法用于复发或难治的大型B细胞淋巴瘤:对社区肿瘤学家的实际意义
机译:AxicabTagene CileOleucel,一种抗CD19嵌合抗原受体T细胞治疗,用于复发或难治性大B细胞淋巴瘤:对社区肿瘤学家的实际影响